Health
CanSino to start Phase III trial of COVID-19 vaccine in Saudi – Marketscreener.com
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
… | August 9, 2020
DUBAI, Aug 9 (Reuters) – Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in
talks with Russia, Brazil, Chile and Saudi Arabia to launch a
Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus
type-5 (Ad5) to carry genetic material fro…
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
Noosa News11 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland